Selected article for: "correlation analysis and Pearson correlation analysis"
Author: CV Herst; S Burkholz; J Sidney; A Sette; PE Harris; S Massey; T Brasel; E Cunha-Neto; DS Rosa; WCH Chao; R Carback; T Hodge; L Wang; S Ciotlos; P Lloyd; R Rubsamen
Title: An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design
  • Document date: 2020_2_27
    • ID: i55tm3hh_21
    Snippet: Animals having unwitnessed demise did not have serum samples collected. A Pearson Correlation Analysis was performed to assess relationships between 175 specific cytokine levels and survival. The results are shown in Table 3 . Retrieved sequences were processed using multiple sequence alignment (MSA) via Clustal for the nucleocapsid phosphoprotein [34] . The nucleocapsid phosphoprotein sequences were trimmed down to every possible peptide sequenc.....
    Document: Animals having unwitnessed demise did not have serum samples collected. A Pearson Correlation Analysis was performed to assess relationships between 175 specific cytokine levels and survival. The results are shown in Table 3 . Retrieved sequences were processed using multiple sequence alignment (MSA) via Clustal for the nucleocapsid phosphoprotein [34] . The nucleocapsid phosphoprotein sequences were trimmed down to every possible peptide sequence 9 amino acids in length. 9mers were chosen because they typically represent A subset of these SARS-CoV-2 peptide sequences are present on SARS-

    Search related documents:
    Co phrase search for related documents
    • amino acid and MSA multiple sequence alignment: 1, 2, 3, 4, 5
    • amino acid and multiple sequence alignment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • amino acid and nucleocapsid phosphoprotein: 1, 2, 3, 4, 5, 6, 7, 8
    • amino acid and peptide sequence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • amino acid and SARS peptide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • amino acid and SARS peptide sequence: 1, 2, 3, 4
    • amino acid and sequence alignment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • amino acid and serum sample: 1
    • Clustal MSA multiple sequence alignment and MSA multiple sequence alignment: 1, 2
    • Clustal MSA multiple sequence alignment and multiple sequence alignment: 1, 2
    • Clustal MSA multiple sequence alignment and sequence alignment: 1, 2
    • cytokine level and specific cytokine level: 1, 2
    • length amino acid and multiple sequence alignment: 1
    • length amino acid and peptide sequence: 1, 2, 3
    • length amino acid and SARS peptide: 1, 2
    • length amino acid and sequence alignment: 1, 2
    • MSA multiple sequence alignment and multiple sequence alignment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • MSA multiple sequence alignment and sequence alignment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • multiple sequence alignment and nucleocapsid phosphoprotein: 1, 2